<DOC>
	<DOCNO>NCT00086216</DOCNO>
	<brief_summary>This Phase I/IIa clinical trial identify maximum tolerate dose atiprimod evaluate safety atiprimod patient refractory relapse multiple myeloma .</brief_summary>
	<brief_title>Safety Efficacy Atiprimod Patients With Refractory Multiple Myeloma</brief_title>
	<detailed_description>This multi-center , open-label , dose escalation study intend identify MTD atiprimod alone MTD atiprimod give combination ursodiol . The atiprimod dose escalate sequential cohort . Ten dose level atiprimod plan atiprimod alone dose escalation : 30 , 60 , 90 , 120 , 180 , 240 , 300 , 360 , 420 , 480 mg/day give orally . Six dose level atiprimod plan atiprimod combination ursodiol dose escalation : 180 , 240 , 300 , 360 , 420 , 480 mg/day give orally . The dose ursodiol remain constant cohort ( 300 mg ursodiol orally three time day everyday ) . Up 105 patient participate depend level toxicity observe . Patients assign dose level order study entry .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>documented history multiple myeloma , fail least two prior regimen multiple myeloma , 18 year age old , ECOG ( Zubrod ) PS 0 2 , screen evaluation determine eligibility prior enrollment , sign informed consent form , concomitant therapy medication include corticosteroid chemotherapy may active myeloma , renal insufficiency ( serum creatinine level &gt; 2mg/dL ) , mucosal bleeding , condition opinion Investigator , place patient unacceptable risk he/she participate study . clinically relevant active infection comorbid medical condition . prior malignancy ( within last 3 year ) except adequately treat basal cell squamous cell skin cancer , situ cervical cancer , cancer patient diseasefree least 3 year . patient nonsecretory myeloma . atiprimod potent inhibitor CYP2D6 , patient take drug substrate CYP2D6 ( e.g . beta blocker , antidepressant antipsychotic ) exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Multiple myeloma</keyword>
</DOC>